Skip to content
GreenLight Biosciences logo — A mission-driven biotech using the power of RNA to tackle so...

GreenLight Biosciences

A mission-driven biotech using the power of RNA to tackle some of humanity's greatest challenges.

Founded 2008 United States Medford, United States 182 employees Post-IPO Equity Total: $449.50M Agriculture, Biotechnology +2

General Information

Company Name GreenLight Biosciences
Founded Year 2008
Location United States Medford, United States
Employees 182
Industries Agriculture, Biotechnology, Life Sciences +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with GreenLight Biosciences. To contact GreenLight Biosciences, visit greenlightbiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GreenLight Biosciences compare?

A PDF of GreenLight Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GreenLight Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GreenLight Biosciences

GreenLight Biosciences is a mission-driven public-benefit corporation using the power of nature to develop and commercialize effective, easy-to-use, and environmentally friendly crop protection for farmers. Founded in 2008, the company operates in the Agriculture and Biotechnology industries, with headquarters in the United States. The company recently secured a significant investment of $109.00M in Post-IPO Equity funding on 12 August 2022. The investment was led by a diverse group of influential investors, including Fall Line Capital, S2G Ventures, Rivas Capital, BNP Paribas Asset Management, Symbiosis Group, Insud Pharma, FTX Foundation, Cummings Foundation, Continental Grain Company, and Morningside Venture Investments. GreenLight Biosciences' commitment to harnessing the power of RNA to address critical global challenges positions it as an attractive prospect for venture capital firms seeking to support innovative and impactful ventures in the biotech and agricultural sectors. With its compelling mission and strong financial backing, the company presents an intriguing opportunity for investors looking to contribute to sustainable solutions for some of humanity's greatest challenges.

Business keywords: biotech, RNA technology, public-benefit corporation, crop protection, agricultural innovation, vaccine development, pandemic preparation, plant protection, environmentally friendly, sustainable agriculture, life sciences, innovation, mission-driven, sustainable solutions, pollinator health

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $109.00M 10
Fall Line Capital, S2G Ventures +8
12 Aug 2022
Post IPO Equity $125.50M 10
Pura Vida Investments, S2G Ventures +8
03 Feb 2022
Series D $102.00M 10
Lewis & Clark Ventures, Fall Line Capital +8
16 Jun 2020
Venture Round $17.00M 3
Baird Capital, Xeraya Capital +1
12 May 2020
Venture Round $50.00M 8
Baird Capital, Prelude Ventures +6
08 Jan 2019
Series D $18.00M 6
Lewis & Clark Ventures, Syngenta Ventures +4
13 Sep 2017
Series C Undisclosed 1
Syngenta Ventures
22 Jul 2015
Series B $20.00M -
17 Jun 2015
Series A $1.00M -
20 Dec 2013
Series A $7.00M 2
Khosla Ventures, Kodiak Venture Partners
12 Aug 2013

GreenLight Biosciences Alternatives & Competitors

View All Alternatives
GreenLight Biosciences vs

Crop protection leader with botanical solutions. STK empowers growers around the globe with biopesti...

63 employees
Agriculture, Biotechnology
GreenLight Biosciences vs

Pioneering sustainable pest and disease control with biological and low-chemical solutions for agric...

Venture round
Agriculture, Biotechnology
GreenLight Biosciences vs
Harpe Bio
Harpe Bio United States

Offering natural & sustainable weed-management solutions for organic and conventional agriculture

Debt Financing
11 employees
Agriculture, Biotechnology

FAQ About GreenLight Biosciences

A mission-driven biotech using the power of RNA to tackle some of humanity's greatest challenges.
GreenLight Biosciences was founded in 2008.
GreenLight Biosciences is headquartered in Medford, United States.
GreenLight Biosciences operates in Agriculture, Biotechnology, Life Sciences and AgriTech. Its work centres on biotech, RNA technology, public-benefit corporation and crop protection.
GreenLight Biosciences has approximately 182 employees.
GreenLight Biosciences has completed 10 funding rounds, raising a total of $449.50M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to GreenLight Biosciences include STK bio-ag technologies, AgraQuest, Harpe Bio, FUTURECO BIOSCIENCE, Pulverizadores Fede. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GreenLight Biosciences and STK bio-ag technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GreenLight Biosciences, https://bouncewatch.com/company/greenlight-biosciences, updated 27 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout